Buy Piramal Life Sciences, target Rs 270: Emkay Global
Emkay Global Financial Services has recommended a buy rating on Piramal Life Sciences (PLSL) with a target price of Rs 270. On a replacement cost basis also, PLSLs valuations are attractive
Emkay Global Financial Services has recommended a buy rating on Piramal Life Sciences (PLSL) with a target price of Rs 270. On a replacement cost basis also, PLSLs valuations are attractive